SAMLYN CAPITAL, LLC - 31 Dec 2024 SCHEDULE 13G Report for NEKTAR THERAPEUTICS Common Stock, $0.0001 par value (NKTR)

Filing Manager
SAMLYN CAPITAL, LLC
Reporting Manager
Samlyn Capital, LLC
Security
NEKTAR THERAPEUTICS Common Stock, $0.0001 par value
Symbol
NKTR
Shares outstanding
185,904,769 shares
Disclosed Ownership
9,667,048 shares
Ownership
5.2%
Form type
SCHEDULE 13G
Filing time
14 Feb 2025, 13:49:10 UTC
Date of event
31 Dec 2024
Next filing
15 May 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Samlyn Capital, LLC 5.2% 9,667,048 0 9,667,048 By: Samlyn, LP, its sole member, By: Samlyn, GP, LLC, its general partner, By: /s/ Robert Pohly Robert Pohly/Managing Member*
Samlyn, LP 5.2% 9,667,048 0 9,667,048 By: Samlyn GP, LLC, its general partner, By: /s/ Robert Pohly Robert Pohly/Managing Member*
Robert Pohly 5.2% 9,667,048 0 9,667,048 /s/ Robert Pohly Robert Pohly*